Paper15190879
Top-down proteomics.
Kelleher NL. Anal Chem, 2004. Cited by 327 papers, by iCite.
Cite this record
ConductScience Library. Top-down proteomics. Papers, record 15190879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15190879
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proteomics | Major topic |
| Animals | |
| Biomarkers | |
| Computational Biology | |
| Gas Chromatography-Mass Spectrometry | |
| Multigene Family |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM 067193 | NIGMS NIH HHS | United States | R01GM067193 | PubMed and NIH |
Source NIH RePORTER
Cited by178
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 327 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42916765 | A Streamlined One-Pot Extraction Method Enables High-Sensitivity Top-Down Proteomic Characterization of Phospholamban from Biopsy-Scale Cardiac Tissue. | J Am Soc Mass Spectrom | 2026 | https://conductscience.org/library/papers/42916765 | PubMed |
| 42907642 | Mass Spectrometry-Based Biomarkers in Drug Development. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42907642 | PubMed |
| 42461610 | Top-Down versus Bottom-Up Proteomics in Highly Sensitive LC-MS-Based Profiling of Limited Samples. | Anal Chem | 2026 | https://conductscience.org/library/papers/42461610 | PubMed |
| 42129069 | Proteomic Technology. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42129069 | PubMed |
| 42074247 | Top-Down Mass Spectrometry and Its Current Applications in Biomarker Discovery in Aging and Age-Related Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074247 | PubMed |
| 41459570 | The Road to the Full Sequencing of Natural Frogs' Peptides Relying Solely on Mass Spectrometry. | Mass Spectrom (Tokyo) | 2025 | https://conductscience.org/library/papers/41459570 | PubMed |
| 39641251 | TopDIA: A Software Tool for Top-Down Data-Independent Acquisition Proteomics. | J Proteome Res | 2025 | https://conductscience.org/library/papers/39641251 | PubMed |
| 39193565 | Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry. | ACS Meas Sci Au | 2024 | https://conductscience.org/library/papers/39193565 | PubMed |
| 38188188 | Multidimensional Separations in Top-Down Proteomics. | Anal Sci Adv | 2023 | https://conductscience.org/library/papers/38188188 | PubMed |
| 38013887 | Comprehensive Overview of Bottom-Up Proteomics using Mass Spectrometry. | ArXiv | 2023 | https://conductscience.org/library/papers/38013887 | PubMed |
| 37937372 | Top-Down Proteomics and the Challenges of True Proteoform Characterization. | J Proteome Res | 2023 | https://conductscience.org/library/papers/37937372 | PubMed |
| 37789425 | Recent advances in proteomics and metabolomics in plants. | Mol Hortic | 2022 | https://conductscience.org/library/papers/37789425 | PubMed |
| 37681662 | Considerations for defining +80 Da mass shifts in mass spectrometry-based proteomics: phosphorylation and beyond. | Chem Commun (Camb) | 2023 | https://conductscience.org/library/papers/37681662 | PubMed |
| 37607050 | Comprehensive Characterization of Endogenous Phospholamban Proteoforms Enabled by Photocleavable Surfactant and Top-down Proteomics. | Anal Chem | 2023 | https://conductscience.org/library/papers/37607050 | PubMed |
| 37196155 | TopFD: A Proteoform Feature Detection Tool for Top-Down Proteomics. | Anal Chem | 2023 | https://conductscience.org/library/papers/37196155 | PubMed |
| 37103836 | Current Methods for Identifying Plasma Membrane Proteins as Cancer Biomarkers. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/37103836 | PubMed |
| 36820077 | Integrated top-down and bottom-up proteomics mass spectrometry for the characterization of endogenous ribosomal protein heterogeneity. | J Pharm Anal | 2023 | https://conductscience.org/library/papers/36820077 | PubMed |
| 36818287 | Proteoforms expand the world of microproteins and short open reading frame-encoded peptides. | iScience | 2023 | https://conductscience.org/library/papers/36818287 | PubMed |
| 35386456 | Proteomics as a tool to gain next level insights into photo-crosslinkable biopolymer modifications. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35386456 | PubMed |
| 35286768 | ProSight Annotator: Complete control and customization of protein entries in UniProt XML files. | Proteomics | 2022 | https://conductscience.org/library/papers/35286768 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15190879
GET https://conductscience.org/api/papers/v1/15190879/cited_by?page=2